The Impact of Targeted Systemic Therapy and Radiotherapy on Patients Undergoing Spine Surgery for Metastatic Breast Cancer: A Dual-Institution Study

Friday, February 23, 2024

8:06 AM – 8:09 AM PST

Presenting Author(s)

Hani Chanbour, MD

Spine fellow
Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN
Nashville, TN, US

Co-Author(s)

AA

Amir Abtahi, MD

orthopedic surgeon
Department of Orthopedic Surgery, Vanderbilt University Medi
MA

Mahmoud Ahmed, PhD

Researcher
Vanderbilt University Medical Center
GB

Gabriel Bendfeldt, BS

Medical Student
Vanderbilt University School of Medicine
JC

Jeffrey W. Chen, PGY1

resident
Baylor college of medicine
SC

Silky Chotai, MD

resident
Vanderbilt University Medical Center
Surya Gangavarapu, MD

Medical student
Vanderbilt University School of Medicine
Nashville, TN, US
Matthew Goodwin, MD (he/him/his)

Orthopedic Surgeon
Washington University
Jacob Greenberg, MD, MSCI

Assistant Professor, Neurosurgery
Washington University in St. Louis School of Medicine
St Louis, MO, US
JK

Joshua Koleske, BS

Medical Student
Washington University
LL

Leo Luo, MD

Radiation Oncologist
Department of Orthopedic Surgery, Vanderbilt University Medi
Camilo A. Molina, MD (he/him/his)

surgeon
Washington University
St. Louis, MO, US
BN

Brian Neuman, MD

Surgeon
Washington University
Miguel Ruiz Cardozo, MD, MPH

Postdoctoral fellow
Washington University
St. Louis, Missouri
BS

Byron Stephens, MD

orthopedic surgeon
Vanderbilt University School of Medicine
Scott L. Zuckerman, MD, MPH (he/him/his)

Assistant Professor of Neurological Surgery
Vanderbilt University Medical Center
Nashville, Tennessee

Disclosure(s):

Hani Chanbour, MD: No financial relationships to disclose

Surya Gangavarapu, BS: No financial relationships to disclose

Matthew Goodwin, MD: AO Spine: Board Member/Officer/Trustee (Ongoing); BioNTech: Stock Shareholder (excluding mutual funds) (Ongoing); Johnson & Johnson: Stock Shareholder (excluding mutual funds) (Ongoing); KAIA: Research Grant (Ongoing); Kendall Hunt Publishing: Royalty Recipient (Ongoing); Merck: Stock Shareholder (excluding mutual funds) (Ongoing); Moderna: Stock Shareholder (excluding mutual funds) (Ongoing); NASS: Board Member/Officer/Trustee (Ongoing); Pfizer: Stock Shareholder (excluding mutual funds) (Ongoing); ROM3: Stock Shareholder (excluding mutual funds) (Ongoing)

Jacob Greenberg, MD, MSCI: No financial relationships to disclose

Camilo A. Molina: Augmedics: Advisor (Ongoing); Baxter: Consultant (Ongoing); K2M Stryker Spine: Consultant (Ongoing); Kuros Biosciences AG: Consultant (Ongoing)

Miguel Ruiz Cardozo, MD, MPH: No financial relationships to disclose

Scott L. Zuckerman, MD: Medtronic: Consultant (Ongoing)